PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation

被引:151
作者
Wimmer, Isabella [1 ,2 ]
Tietz, Silvia [1 ]
Nishihara, Hideaki [1 ]
Deutsch, Urban [1 ]
Sallusto, Federica [3 ,4 ]
Gosselet, Fabien [5 ]
Lyck, Ruth [1 ]
Muller, William A. [6 ]
Lassmann, Hans [2 ]
Engelhardt, Britta [1 ]
机构
[1] Univ Bern, Theodor Kocher Inst, Bern, Switzerland
[2] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria
[3] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland
[4] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland
[5] Univ Artois, Blood Brain Barrier Lab, Lens, France
[6] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
基金
瑞士国家科学基金会; 奥地利科学基金会;
关键词
blood-brain barrier; endothelial junctions; PECAM-1; T-cell diapedesis; vascular permeability; multiple sclerosis; ADHESION MOLECULE-1 PECAM-1; PROTEIN-TYROSINE-PHOSPHATASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; IN-VITRO; TRANSENDOTHELIAL MIGRATION; GELATINASE-B; LEUKOCYTE EXTRAVASATION; TRANSCELLULAR MIGRATION; VASCULAR-PERMEABILITY;
D O I
10.3389/fimmu.2019.00711
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Breakdown of the blood-brain barrier (BBB) and increased immune cell trafficking into the central nervous system (CNS) are hallmarks of the pathogenesis of multiple sclerosis (MS). Platelet endothelial cell adhesion molecule-1 (PECAM-1; CD31) is expressed on cells of the vascular compartment and regulates vascular integrity and immune cell trafficking. Involvement of PECAM-1 in MS pathogenesis has been suggested by the detection of increased levels of soluble PECAM-1 (sPECAM-1) in the serum and CSF of MS patients. Here, we report profound upregulation of cell-bound PECAM-1 in initial (pre-phagocytic) white matter as well as active cortical gray matter MS lesions. Using a human in vitro BBB model we observed that PECAM-1 is not essential for the transmigration of human CD4(+) T-cell subsets (Th1, Th1*, Th2, and Th17) across the BBB. Employing an additional in vitro BBB model based on primary mouse brain microvascular endothelial cells (pMBMECs) we show that the lack of endothelial PECAM-1 impairs BBB properties as shown by reduced transendothelial electrical resistance (TEER) and increases permeability for small molecular tracers. Investigating T-cell migration across the BBB under physiological flow by in vitro live cell imaging revealed that absence of PECAM-1 in pMBMECs did not influence arrest, polarization, and crawling of effector/memory CD4+ T cells on the pMBMECs. Absence of endothelial PECAM-1 also did not affect the number of T cells able to cross the pMBMEC monolayer under flow, but surprisingly favored transcellular over paracellular T-cell diapedesis. Taken together, our data demonstrate that PECAM-1 is critically involved in regulating BBB permeability and although not required for T-cell diapedesis itself, its presence or absence influences the cellular route of T-cell diapedesis across the BBB. Upregulated expression of cell-bound PECAM-1 in human MS lesions may thus reflect vascular repair mechanisms aiming to restore BBB integrity and paracellular T-cell migration across the BBB as it occurs during CNS immune surveillance.
引用
收藏
页数:17
相关论文
共 108 条
[1]   Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier [J].
Abadier, Michael ;
Jahromi, Neda Haghayegh ;
Alves, Ludmila Cardoso ;
Boscacci, Remy ;
Vestweber, Dietmar ;
Barnum, Scott ;
Deutsch, Urban ;
Engelhardt, Britta ;
Lyck, Ruth .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (04) :1043-1058
[2]   EXPRESSION OF CD31-EPITOPES ON HUMAN-LYMPHOCYTES - CD31-MONOCLONAL ANTIBODIES DIFFERENTIATE BETWEEN NAIVE (CD45RA+) AND MEMORY (CD45RA-) CD4-POSITIVE T-CELLS [J].
ASHMAN, LK ;
AYLETT, GW .
TISSUE ANTIGENS, 1991, 38 (05) :208-212
[3]   Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction [J].
Babbe, H ;
Roers, A ;
Waisman, A ;
Lassmann, H ;
Goebels, N ;
Hohlfeld, R ;
Friese, M ;
Schröder, R ;
Deckert, M ;
Schmidt, S ;
Ravid, R ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :393-404
[4]   Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[5]  
Bauer J, 2016, METHODS MOL BIOL, V1304, P211, DOI 10.1007/7651_2014_151
[6]  
BIRD IN, 1993, IMMUNOLOGY, V80, P553
[7]   PECAM-1 affects GSK-3β-mediated β-catenin phosphorylation and degradation [J].
Biswas, Purba ;
Canosa, Sandra ;
Schoenfeld, David ;
Schoenfeld, Jonathan ;
Li, Puyau ;
Cheas, Lydia C. ;
Zhang, Jin ;
Cordova, Alfredo ;
Sumpio, Bauer ;
Madri, Joseph A. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (01) :314-324
[8]   MONOCLONAL-ANTIBODY TO MURINE PECAM-1 (CD31) BLOCKS ACUTE-INFLAMMATION IN-VIVO [J].
BOGEN, S ;
PAK, J ;
GARIFALLOU, M ;
DENG, XH ;
MULLER, WA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1059-1064
[9]   MONOCYTE-MACROPHAGE DIFFERENTIATION IN EARLY MULTIPLE-SCLEROSIS LESIONS [J].
BRUCK, W ;
PORADA, P ;
POSER, S ;
RIECKMANN, P ;
HANEFELD, F ;
KRETZSCHMAR, HA ;
LASSMANN, H .
ANNALS OF NEUROLOGY, 1995, 38 (05) :788-796
[10]  
Buckley CD, 1996, J CELL SCI, V109, P437